EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
64 hedge funds and large institutions have $332M invested in Evelo Biosciences, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 23 increasing their positions, 15 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
49% less capital invested
Capital invested by funds: $645M → $332M (-$314M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
64
Holding in Top 10
2
Calls
$4.87M
Puts
$6.53M
Top Buyers
| 1 | +$1.52M | |
| 2 | +$1.41M | |
| 3 | +$1.13M | |
| 4 |
Bessemer Group
Woodbridge,
New Jersey
|
+$431K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$342K |
Top Sellers
| 1 | -$550K | |
| 2 | -$472K | |
| 3 | -$464K | |
| 4 |
Amundi
Paris,
France
|
-$446K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$268K |